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Background: Sickle cell disease (SCD) is a genetically inherited hemoglobinopathy in which deoxygenated hemoglobin S polymerizes, leading to stiff red blood cells (RBCs) and inefficient microcirculatory blood flow. Transfusion therapy acts as primary and secondary prevention of ischemic stroke in SCD. Whether blood transfusion alters the mechanical sensitivity (MS) of RBCs to prolonged subhemolytic shear stress (shear) is unknown. We hypothesized that individuals with SCD undergoing chronic blood transfusion would have improved sensitivity to shear, compared with patients not undergoing transfusion therapy.
Study Design and Methods: Blood suspensions from individuals with SCD not receiving (n = 15) and receiving (n = 15) chronic simple transfusion were conditioned to shear (1, 4, 16, 32 , and 64 Pa) for various durations (1, 4, 16, 32 , and 64 sec), and then deformability of RBCs was immediately measured. Healthy young controls (n = 15) were included for reference. A surface mesh was interpolated using the data to determine the effect of blood transfusion on MS of RBCs.
Results: There was impaired RBC deformability to prolonged supraphysiologic shear in both SCD groups; however, MS improved in transfused patients when exposed to prolonged physiologic shear. Furthermore, in the transfused patients with SCD, the threshold above which subhemolytic damage occurs was similar to controls.
Conclusion:
We found that chronic transfusion therapy normalizes the MS threshold above which RBC subhemolytic damage occurs after prolonged shear exposure in SCD. An important and novel finding in transfused patients with SCD was the improvement in RBC deformability in response to prolonged shear exposure over the physiologic range.
I n certain regions of the world, sickle cell disease (SCD) is still fatal within the first years of life; however, increased lifespan in developed countries has elevated the incidence of chronic vascular disease and end-organ damage 1 . SCD stems from a single point modification in the β-globin gene, resulting in a mutant β-globin chain that, when combined with α-globin, forms hemoglobin (Hb) S. 2 When red blood cells (RBCs) traverse the capillary network, Hb S releases oxygen to the tissue and transitions from the R state to the T state, resulting in Hb S polymer formation. Polymerization is reversible and thought to be ongoing, even in discoid RBCs. [3] [4] [5] Polymerization results in decreased RBC deformability of discoid RBCs, and in some RBCs, overt sickling occurs. 6 Cyclic polymerizationdepolymerization events decrease the cell's capacity to dynamically change shape in response to mechanical stress (i.e., dynamic change in RBC deformability). This process uses energy, and with chronic cycling of Hb polymers, mechanical damage accumulates in the cell, ultimately resulting in hemolysis. 7 Acute and chronic transfusions of AA RBCs are disease modifying in SCD, providing both chronic prevention of and acute therapy for complications associated with the disease. Acute transfusion may be used during splenic sequestration, aplastic crises, acute chest syndrome, and stroke. 8 Chronic transfusion therapy serves as both primary and secondary prevention of stroke but may also be used for unremitting pain crises and pulmonary hypertension. Despite the benefits of blood transfusion, it has been reported over several decades that blood storage increases the fragility of RBCs and impairs cellular deformability. [9] [10] [11] This may predispose transfused AA RBCs to mechanical damage, and thus depending on the percentage of AA versus SS RBCs, cell mechanics in transfused patients may still be suboptimal. Although exposure of RBCs to shear stress (shear) facilitates cellular deformation and aligns cells with fluid flow, exposure to shear well above the peak levels within the human circulation of approximately 10 to 15 Pa 12 is damaging to cells. Recent studies demonstrate that supraphysiological shear-as induced by rotary blood pumpscaused sublethal trauma 13, 14 to RBCs, even when levels were below that required to induce hemolysis. 15 Although historically rare, chronic cardiovascular complications occur because of improved survival and, thus, patients with SCD may require cardiac surgery requiring cardiopulmonary bypass. It has been reported that individuals with SCD received extracorporeal membrane oxygenation treatment in the management of acute chest syndrome 16, 17 and, more recently, cardiac dysfunction, 18 despite the associated high shear environment of these blood circuits.
Little is known about the effect of subhemolytic shear (i.e., shear levels that are supraphysiological yet below that which induces hemolysis) on RBCs from individuals with SCD who are undergoing chronic transfusion. Given this gap in knowledge about the effects of prolonged subhemolytic shear on RBCs, we investigated how varied duration and magnitude of shear influence RBC mechanical sensitivity (MS) in individuals with SCD undergoing chronic blood transfusion therapy. Our hypothesis was that RBCs from individuals with SCD undergoing chornic blood transfusion would have improved MS after exposure to prolonged shear, when compared with nontransfused patients with SCD.
MATERIALS AND METHODS

Subjects and sample preparation
Patients with SCD, both nontransfused and chronically transfused, were enrolled from the hematology clinic and transfusion center at Children's Hospital Los Angeles. Patients undergoing chronic transfusion therapy were receiving simple transfusion every 2 to 3 weeks with the goal to regulate Hb S to <30% of total Hb. Control subjects were enrolled from a convenience sample at Griffith University. All subjects volunteered to provide a blood sample after informed consent was obtained. Controls were free from known disease and were not taking any medications. Blood was drawn using a 21-gauge needle from a peripheral vein into heparinized vacuum tubes, well mixed, and then placed on a slowly rotating roller until analyses. Blood collection was completed within 90 seconds of tourniquet application, and all experiments were done within 4 hours of sampling. Blood collection methods were consistent with recommendations for hemorheological assessment to minimize cell disruption and to standardize shear forces on samples. 19 The study protocol was consistent with The Code of Ethics of the World Medical Association (Declaration of Helsinki) and was reviewed and approved by the Institutional Review Boards at Children's Hospital Los Angeles and Griffith University.
Sample preparation
The experimental protocol for each subject (see below) required the use of 27 RBC suspensions for all measurements to be completed; these were prepared in small batches (five samples per batch) immediately before analysis. The suspensions were prepared by diluting 1:200 whole blood in a viscous, isotonic solution of polyvinylpyrrolidone (PVP; 360,000 Da, dissolved in 0.1 mol/L phosphate-buffered saline; typical viscosity = 28.1 mPaÁs at 37 C, pH = 7.39, 289 mOsmol/kg; Mechatronics Instruments B.V.). All samples were analyzed within 10 minutes of preparation.
Experimental design
The experimental design involved three phases: 1) determination of unsheared RBC deformability to provide a baseline, 2) a "conditioning" shearing period at a specific level and duration of shear, and 3) the subsequent determination of RBC deformability immediately after the conditioning period. This protocol has been described in detail previously.
14 RBC deformation in response to an applied fluid shear for unsheared cells was determined using a laser-diffraction ektacytometer system (see "RBC deformability measurements"); these data provided the baseline values of RBC deformability. Subsequently, freshly prepared RBC suspensions were exposed to a conditioning stimulus that consisted of a given level of shear for a specific duration. The magnitudes of shear were 1, 4, 16, 32, and 64 Pa. Each shear level was used with a new sample for a given duration, where the durations were 1, 4, 16, 32, and 64 seconds. Thus, each assay consisted of a baseline measurement of unsheared cells (i.e., baseline) and RBC suspensions subjected to 25 conditioning stimuli: five levels of shear and five exposure times (i.e., 1 Pa × 1 sec, 1 Pa × 4 sec … 64 Pa × 32 sec, 64 Pa × 64 sec) in a randomized order. Baseline measurements on unsheared RBCs were repeated at the end of each experiment to determine whether ex vivo ageing influenced RBC deformability.
RBC deformability measurements
RBC deformability was measured using a concentric cylinder ektacytometer (LORRCA MaxSis; Mechatronics Instruments B.V.) operating at 37 AE 1 C. Dilute suspensions of RBCs in the viscous PVP solution were gently transferred into the gap between the cup and bob of the instrument, and air bubbles were cleared while the sample was slowly sheared (0.1 rev/s; shear, 0.2 Pa) to allow temperature equilibration. The RBC suspension was then subjected to various shear, ranging from 0.3 to 50 Pa. A low-power laser beam (670 nm, 4 mW) projected from the bob, through the sample and cup, and onto a small projection screen. The laser beam generated a diffraction pattern that was circular for cells at rest and became progressively ellipsoidal as RBCs deformed with shear. Diffraction patterns were captured by an integrated closed coupled device camera and analyzed in real time by fitting an ellipse to the region of interest. An elongation index (EI) of the diffraction pattern was calculated as follows, on the basis of the geometry of the ellipse: EI = (length − width)/(length + width).
Hematologic measures
Heparinized samples were also analyzed to evaluate hematocrit, Hb levels, white blood cell (WBC) fractions, and platelet count. Electrophoresis was used to determine Hb fractions (i.e., Hb A, S, and F) in individuals with SCD. Markers of hemolysis included concentrations of plasmafree Hb, lactate dehydrogenase, and bilirubin.
Data analysis
Data generated by the ektacytometer were analyzed using a commercial analytical software program using a nonlinear regression approach (Prism, Release 7.02; GraphPad Software Inc). RBCs previously exposed to high stresses for longer periods exhibited atypical EI data when deformability was measured below 0.94 Pa, and hence using such EI values yielded nonsigmoidal EI-shear curves and spurious curve-fit parameters. This has been described elsewhere as sickle RBC tumbling at low shear, creating a "cross-shape" pattern that is inaccurate for EI determination. 20 All data for regression analyses were thus truncated, and curves were only fit to EI-shear data over the range of 0.94 to 50.0 Pa. Nonlinear regression 21 yielded the following indexes: 1) the maximum theoretical EI at infinite shear (EI max ) and 2) the shear required for half of EI max (SS 1/2 ). The ratio SS 1/2 /EI max was used to scale for changes of maximal deformation. Decreased RBC deformability yields an increased SS 1/2 and a decreased EI max , hence an increased ratio. An MS parameter was calculated for all samples using the formula previously reported 22 :
where n represented the specific level-duration of shear exposure, and BL represented the unsheared baseline value.
Surface plots were produced by creating an x, y, z matrix of the mean MS data for all subjects, where z was MS, and x and y represented the duration and magnitude of shear exposure, respectively (Origin, Release 8; OriginLab Corp). Thinplate splines were used to interpolate the raw x, y, z matrix, and a surface plot of the matrix facilitated visual identification of the subhemolytic threshold. The subhemolytic threshold was conservatively considered to occur at the 95% confidence interval (CI) above the baseline mean for MS. That is, if an MS value was >95% of the CI of the baseline mean, this value was considered outside the expected range and, thus, indicated impairment of RBC deformability. All MS values between −95% and 95% CIs of the baseline mean were considered "normal" and, thus, not affected by the conditioning protocol.
Various models were pilot tested to describe the relation between the level of shear and exposure duration: twoand three-component exponentials had poorer predictive power (r 2 ) than a single-exponential decay curve fit, whereas second-, third-, fourth-, fifth-, and sixth-order polynomial curve fits either did not fit the data or were again poorer fits (r 2 ) of the raw data. Consequently, the most robust fit of the level of shear and exposure duration was found using the monoexponential equation using nonlinear least-squares regression (Prism, Release 7.02).
Statistical analysis
Results are reported as mean AE SEM. Normality of the data was confirmed using the D'Agostino and Pearson omnibus normality test (Prism, Release 7.02). Data for each condition were compared using an appropriate analysis of variance, with repeated measures when necessary, to determine whether significant differences in the means existed (Release 20.0; SPSS Inc). Post hoc comparisons were analyzed using Tukey's corrections when appropriate. Significance was determined at an α level of 0.05.
RESULTS
Patient characteristics and hematological profile
The patient demographics, anthropometric data, and hematological measures are reported in Table 1 . We enrolled 30 patients with SCD (15 were undergoing chronic transfusion and 15 were not transfused: 43% were female; age was 17 AE 6 yr). We also enrolled 15 healthy subjects: 20% were female; age was 20 AE 1 year. The SCD groups presented with typical hematology variations when compared with controls: they were anemic and had evidence of chronic inflammation and chronic hemolysis. The two SCD groups were well matched for height and body mass. We only measured pretransfusion laboratory values, and they were not significantly different from nontransfused patients for WBCs, platelets, RBCs, or reticulocytes. Total Hb was not different between SCD groups. However, significant differences were detected, as expected, for Hb variants: nontransfused patients had significantly elevated Hb S and Hb F, and significantly decreased expression of Hb A, when compared with the transfused group in the present study (all p < 0.001). The nontransfused group presented with 10% larger RBCs (i.e., increased mean corpuscular volume) when compared with patients undergoing chronic transfusion, which is likely because of hydroxyurea use (p = 0.003). No significant differences were observed between SCD groups for markers of hemolysis: plasma-free Hb and lactate dehydrogenase were similar between groups, although bilirubin concentration was significantly higher in transfused when compared with nontransfused patients (p = 0.013).
RBC deformability was improved in the group undergoing chronic transfusion RBC deformability for each group is illustrated in Fig. 1 . The RBC deformability response to shear was typically sigmoidal (Fig. 1A) , with increased deformation observed on application of higher shear levels. When compared with typical values for individuals without SCD (controls), both transfused and nontransfused patients demonstrated impaired RBC deformability. Impaired RBC deformability in the transfused group was partially ameliorated compared with the nontransfused group (F = 7.715; p = 0.010). Specifically, EIs were increased for transfused individuals at shears of 2.81 Pa (p = 0.029), 5.00 Pa (p = 0.009), and 8.89 Pa (p = 0.035), when compared with the nontransfused group. The SS 1/2 /EI max parameter (Fig. 1B) , a simplified and summative metric of RBC deformability, 21 was also improved for transfused patients (p = 0.003).
Effects of prior exposure to shear on RBC deformability
The RBC deformability (i.e., SS 1/2 /EI max ) response to varying conditioning shear is illustrated in Fig. 2 for the SCD groups. The deformability of RBCs measured without prior shear conditioning before (Pre) and after (Post) the experiment is presented for comparative purposes. For all combinations of conditioning shear and exposure duration, RBCs were more deformable in the transfused group, compared with the nontransfused group. There was no effect of ex vivo aging on RBC deformability (i.e., Pre vs. Post measurements); therefore, all responses we documented were the result of conditioning shear. In the nontransfused group, conditioning at 1, 4, and 16 Pa for all exposure durations (1-64 sec) did not influence deformability. When conditioned for 64 seconds at 32 Pa, RBCs became less deformable (p = 0.022). Conditioning at 64 Pa significantly worsened deformability over all exposure durations -1 second (p = 0.024), and 4, 16, 32, and 64 seconds (all p < 0.001, inclusive). Unique responses were observed after conditioning shear in the transfused group with SCD: we found both impaired RBC deformability and improved RBC deformability, which were dependent on shear conditioning. Conditioning at 4 Pa (4, 16, 32, and 64 sec; all p < 0.001), 16 Pa (1, 4, 16, 32, and 64 sec; all p < 0.01), and 32 Pa (1, 4, 16, and 32 sec; all p < 0.05) significantly improved RBC deformability in the transfused group. Impaired deformability was also observed, however, in the transfused group but only after conditioning at 64 Pa for 16, 32, and 64 seconds (all p < 0.001).
A surface mesh indicating RBC sensitivity to conditioning shear (i.e., MS) is illustrated in Fig. 3 . The magnitude of MS was greater at all combinations of shear and exposure duration in the two SCD groups when compared with controls, although there was a prominent amelioration in the transfused group. The upper 95% CI for the MS data (solid white line > 95% CI; Fig. 3 ) was found to occur at 9.0% in nontransfused (Fig. 3, left) and 7.9% in transfused (Fig. 3,  right) , which indicates significant sublethal mechanical impairments occurs above this point. Critical levels of MS (i.e., >95% CI) demonstrated an inverse relation between shear and duration. Peak MS reached 50% at 64 Pa × 64 seconds in the nontransfused group, which is approximately 25% greater than the corresponding value in the transfused group (40% at 64 Pa × 64 sec).
The upper 95% CI of the MS (Fig. 3) can be described using a monoexponential decay of the shear level and exposure duration: the duration-magnitude interactions required to impair RBC deformability (i.e., >95% CI) are shown in Fig. 4 
DISCUSSION
We aimed to determine the effects of prolonged shear on the MS of RBCs by assessing induced changes in cellular deformability, an important determinant of microcirculatory blood flow and tissue oxygenation. We observed that RBC MS improves after conditioning with physiologic, and moderate supraphysiological, levels of shear in control subjects and patients with SCD undergoing chronic transfusion therapy (Figs. 2 and 3) . No improvements in RBC MS were observed, however, in a matched group of nontransfused patients. Moreover, the threshold above which subhemolytic damage occurs was normalized in patients with SCD undergoing chronic transfusion (Fig. 4) , although the absolute cell mechanics at this point were still not completely reflective of individuals without SCD (i.e., controls). Collectively, these MS findings provide new insight into biomechanical improvements to RBCs that supersede standard measures of deformability, which is crucial when evaluating RBC mechanics in flowing systems, such as blood pumps, and in the human microcirculation. There are several potential mechanisms underlying the improved RBC deformability after prolonged exposure to physiologic shear (Figs. 2 and 3) and the subhemolytic presented with significantly improved RBC deformability when compared with the nontransfused group ( ). Typical RBC deformability for individuals without SCD is provided as a point of reference. The SS 1/2 expressed relative to EI max was significantly impaired in both SCD groups compared with Con, although the transfused group (B) was significantly improved when compared with the nontransfused group. Significant differences between groups: ** p < 0.01, *** p < 0.001.
threshold above which adverse mechanical changes occur (Fig. 4) , including the following: 1) dilution of SS RBCs with AA RBCs; 2) RBC membrane or cytosolic modifications that act to modulate MS; and 3) improved plasma environment, which may reflect decreased chronic inflammation and products of hemolysis. Dilution of SS RBCs with AA RBCs likely plays a shortterm role in our findings; however, our experimental setup does not allow us to predict the fraction of SS RBCs that must be achieved to maximize the improvement in MS. Over the short lifetime of RBCs in patients with SCD, blood is continuously exposed to varying shear across the vascular network, the level and duration of which are principally determined by dynamic relations between fluid viscosity, flow rate, cell biophysical properties, and vascular geometry. In SCD, RBCs are less deformable in general and worsen on deoxygenation, increasing viscosity and, thus, local shear. SS RBCs adhere to the endothelium, which leads to vascular pruning and altered vascular geometry, 23 further altering local shear. With accumulated shear exposure, SS RBCs are particularly susceptible to overt hemolysis, although it is presently apparent that subhemolytic trauma also accumulates, resulting in microparticle formation. RBC microparticle formation is well known in SCD and has been linked to both physiologic and clinical outcome measures. 24 Therefore, the implications of these data directly relate to a key question in SCD and transfusion therapy, both short-and chronic: what is the optimal SS Fig. 2 . Deformability of RBCs (expressed as SS 1/2 /EI max ) measured immediately after exposure to discrete shears (1, 4, 16, 32, 64 Pa) for specific durations (1, 4, 16, 32 , and 64 sec). We also measured RBC deformability in samples that were not conditioned with shear at the start of the study and again at the end (Pre and Post, respectively); this allowed us to determine whether deformability changes were attributable to shear application or ex vivo aging. Data are grouped by whether patients had a history of chronic transfusion therapy. Significant differences after conditioning were noted when compared with preconditioning values for the following: † nontransfused patients and ‡ patients undergoing chronic transfusion.
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RBC fraction required to confer maximum benefit, while inducing the least burden on typically tissue-poor blood banks? MS appears to be a potential biomarker that may prove useful in addressing this question. The mechanism by which cellular deformability actually improved after short-term (1-64 sec) exposure to shear within the physiological range (i.e., 4-16 Pa; Fig. 2 ) is unclear because this has not been observed previously in SCD and was only recently reported in healthy subjects. 25 Potential mechanisms for these changes include RBC membrane mechanosensitive changes that alter cellular transport of water and calcium, and nitric oxide (NO) produced locally by a NO synthase (NOS) isoform. 26 RBC-NOSderived NO may have the capacity for maintaining intracellular NO balance and modulating RBC deformability. [27] [28] [29] Intracellular NO has the capacity to bind thiol groups (i.e., S-nitrosylation), and when RBC cytoskeletal proteins (specifically α and β spectrins) are S-nitrosylated, improved cellular deformability has been observed. 30 It has also been shown that nitrogen oxides may play a role in Gardos channel modification, causing the cells to maintain hydration, thus improving RBC deformability. 27 Studies exploring such pathways under shear have been limited in SCD, and findings on the capacity for RBC-NOS to enhance 31 or impair 32 cellular deformability in these patients are conflicting. These studies have only explored basal RBC-NOS activity and its correlation with RBC deformability. To our knowledge, no studies have explored shear-mediated RBC-NOS activation and cellular deformability in a well-controlled dynamic system using SS RBC. For the plasma suspending environment, chronic transfusion therapy has been shown to improve vascular function in medium-sized arteries and single measures of RBC deformability, but it did not normalize markers of inflammation or hemolysis. 33 The Stroke Prevention Trial in Sickle
Cell Anemia (STOP) 34 was a randomized controlled trial with plasma hemoglobin levels measured before the initiation of transfusion therapy, and then again after 1 year of chronic transfusion therapy. Patients in STOP had significantly elevated plasma hemoglobin levels at a baseline, being 78.7 mg/dL before initiation of transfusion therapy. After 1 year of transfusion therapy, patients with SCD achieved a level of 34.2 mg/dL. The plasma-free hemoglobin levels we observed (transfused, 28.0 mg/dL; nontransfused, 32.0 mg/dL) are similar to those published in STOP after 1 year on chronic transfusion, although our study was cross-sectional and did not have plasma-free hemoglobin measurements before the initiation of the transfusion therapy. Our data are nevertheless consistent with previous reports and indicate that, although transfusion is effective for reducing plasma-free hemoglobin, it does not normalize to levels comparable with healthy controls. The subhemolytic threshold observed in our nontransfused patients with SCD was lower (i.e., worse) when compared with our current healthy control group as well as previous reports in normal RBCs. 14 More important, subhemolytic trauma was observed at shear levels well below that induced by rotary blood pumps used for cardiopulmonary bypass or ventricular assist devices. 35 In our transfused patients, however, no detectable impairment in RBC deformability was observed until conditioning reached 64 Pa for at least 16 seconds. Thus, simple transfusion in SCD has the capacity to substantially reduce the susceptibility of RBCs to mechanical impairments that result from prolonged shear exposure. This may be important when determining transfusion protocols for surgeries in our surviving population of patients with SCD who require cardiovascular surgery. Considering SCD is listed on the current exclusion criteria for popular ventricular assist devices (e.g., Berlin Heart 36 ), these findings may affect certain strategies for cardiovascular therapies (surgical and otherwise). Although we have found an improvement in RBC MS with chronic transfusion therapy, our study has some limitations. We are not able to directly link our findings with improved microcirculatory function and tissue oxygenation, nor confirm a specific mechanistic explanation for these observations. The cross-sectional nature of this study also limits our ability to understand how this finding changes with time, which is important for our understanding of chronic vascular disease. Our working hypothesis is that dilution of Hb S RBCs with healthy RBCs results in a shortterm improvement in population RBC deformability and cell mechanics. However, long-term improvements are likely because of enhanced intracellular and cell-cell signaling of molecules known to augment deformability.
In conclusion, we found that chronic transfusion therapy normalizes the MS threshold above which RBC subhemolytic damage occurs after prolonged shear exposure in SCD. An important and novel finding was the improvement in RBC deformability of patients with SCD in response to prolonged shear exposure over the physiologic range.
